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Abstract 
The knowledge of the cellular events occurring in the aging heart has dramatically expanded in the last 
decade and is expected to further grow in years to come. It is now clear that impaired function and loss 
of cardiomyocytes are major features of cardiac aging, but other events are likewise important. In 
particular, accumulating experimental evidence highlights the importance of fibroblast and cardiac 
progenitor cell (CPC) dysfunction. The Notch pathway regulates cardiomyocyte, fibroblast and CPC 
activity and, thus, may be critically involved in heart disease associated with advanced age, especially 
heart failure. In a translational perspective, thorough investigation of the Notch system in the aging 
myocardium may lead to the identification of molecular targets for novel therapies for age-related 
cardiac disease. This article is protected by copyright. All rights reserved 
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Introduction 
Aging profoundly affects cardiac structure and function (Chen and Frangogiannis, 2010). Age-
related remodelling of the heart contributes to the limitation in exercise capacity typical of the 
elderly. Furthermore, it often prepares the ground for the development of cardiac disease, 
especially heart failure (HF), but also arrhythmia and ischemic heart disease. Cardiac 
deterioration during the late phase of life may be in part ascribed to cardiomyocyte impairment 
and death, which have been the focus of research for many years in the field of cardiac aging 
(Sheydina et al, 2011). More recently, two major conceptual breakthroughs have opened new 
perspectives in the study of the mechanisms that make the heart old and predispose to HF and 
other types of cardiac disease: i) fibrosis is as important for cardiac pathology as cardiomyocyte 
dysfunction or loss, and ii) the evidence that the heart can, in principle, regenerate.  
The first two paragraphs of this review will address these two aspects with respect to cardiac 
aging. As a consequence of understanding the importance of fibrosis and heart regeneration, 
interest has arisen in the identification of signaling pathways affecting cells responsible for these 
processes, i.e. fibroblasts and cardiac progenitor cells (CPC), respectively. This appears to be the 
case with the Notch system, which is discussed in the third paragraph.  This review is a result of 
a systematic literature search by Pubmed (simple subjects search) using the following key 
concepts: Notch receptors, Notch ligands,  heart, aged endothelium, aged heart, cardiac 
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1. Cardiac Fibrosis and Aging 
The complexity of heart function is accounted for by a complicated tissue organization, where 
cardiomyocytes are bundled together in close spatial relation with several other cell types, among 
which a major role is played by fibroblasts and the intramural coronary vasculature. This 
cytoarchitecture is ensured by the extracellular matrix (ECM), which enwraps cardiac cells and 
vessels, connecting one to another, and continues with the chordae tendineae, valve annuli and 
leaflets (Bowers et al, 2010;Rienks et al, 2014;Li et al, 2014). It is now established that ECM 
does not simply provide physical support to cardiomyocytes, but also exerts functional roles. 
Indeed, it keeps myofibers aligned and prevents their overstretching or slippage, integrates the 
contraction of individual cardiomyocytes into coordinated apical-to-basal cardiac shortening, and 
avoids chamber deformation when blood pressure or volume increase (Bowers et al, 2010;Rienks 
et al, 2014;Li et al, 2014). Furthermore, binding of components of the ECM to membrane 
receptors and the cytoskeleton of parenchymal cells converts mechanical stimuli into 
biochemical signals. The ECM is made of proteins and other macromolecules, such as 
glycoproteins and proteoglycans (Bowers et al, 2010). Collagen is the most abundant protein 
within the ECM; the enzyme lysil oxidase crosslinks extracellular collagen to form collagen 
fibrils, which then further assemble in very resistant fibres. The amount of ECM is the result of 
the balance between new synthesis and degradation. If ECM deposition outweighs breakdown, 
fibrosis ensues (Li et al, 2014;Rienks et al, 2014). Traditionally, fibrosis that develops following 
cardiomyocyte necrosis is referred to as “reparative”, while the term “reactive” is used to 
indicate fibrosis involving the perivascular spaces and interstitium and not initiated by 
cardiomyocyte death. Activated fibroblasts, namely myofibroblasts, are primarily implicated in 
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myofibroblasts in the adult heart is limited to valvular leaflets. Following injury or disease, the 
number of myofibroblasts dramatically increases mainly because of the activation and 
differentiation of resident fibroblasts. Myofibroblasts produce ECM by default, as a protective 
reaction aiming at maintaining tissue homeostasis (Goldsmith et al, 2014;Li et al, 2014;Rienks et 
al, 2014). In case of myocardial infarct (MI), this process leads to the formation of a scar that 
protects against ventricular wall rupture: if the heart is exposed to pressure or volume overload, 
myofibroblast-driven fibrosis cooperates with cardiomyocyte hypertrophy in diminishing parietal 
stress. Nevertheless, fibrosis becomes detrimental in the long term (Burchfield et al, 2013). 
Indeed, at the cellular level, it entraps cardiomyocytes, hindering oxygen and nutrient supply and 
causing atrophy, while predisposing to arrhythmia by interfering with the transmission of 
electrical impulses. In addition, myofibroblasts release factors that alter cardiomyocyte function 
via paracrine modulation or through heterocellular myofibroblast-cardiomyocyte gap junctions. 
As far as cardiac mechanics is concerned, accumulation of ECM may eventually stiffen the heart 
or impair the generation of an integrated contractile force, leading to diastolic or systolic 
dysfunction, respectively.  
Current evidence indicates that aging is characterized by enhanced cardiac fibrogenesis (Chen 
and Frangogiannis, 2010). The old heart contains more collagen than the younger one and 
experimental data suggest that ECM degradation decreases with aging. Furthermore, it has been 
reported that collagen cross-linking is increased (de Souza, 2002). These abnormalities in ECM 
turnover are paralleled by recruitment and activation of fibroblasts. Several signals may lead to 
this fibroblast dysregulation, among which transforming growth factor (TGF)-β and angiotensin 
II have long been known (Brooks and Conrad, 2000;Billet et al, 2007). As new factors 
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signaling networks responsible for age-related fibrosis are extremely complex and, at least in 
part, specific to the fibroblast lineage. For instance, chronic low-grade inflammation has been 
shown to be a key player in inducing myofibroblast differentiation from myeloid precursors 
(Cieslik et al, 2011). On the other hand, the low-density lipoprotein receptor, LOX-1, has been 
inversely correlated with cytoskeletal disorganization, reduced proliferation, and increased 
collagen secretion in aged cardiac fibroblasts (Wang et al, 2013), despite this receptor being 
classically induced by pro-inflammatory cytokines. While fibrogenesis is basally enhanced, the 
fibrotic response to MI in preclinical murine models appears to be paradoxically impaired with 
aging (Bujak et al, 2008;Cieslik et al, 2013). Fibroblasts infiltration of the infarcted area is 
significantly lower in old than young animals and, consistently, collagen deposition is decreased. 
As a result, the scar that forms is defective and maladaptive dilative cardiac remodeling occurs. 
Efforts have been put to solve this apparent conundrum, i.e. that baseline fibrosis is augmented in 
the aging heart, while the one induced by MI is blunted. A possible explanation resides in the 
fact that myofibroblasts derive from different cell populations. Specifically, it has been proposed 
that a population of non-myeloid mesenchymal stem cells (MSCs) within the myocardium 
becomes unresponsive to TGF-β with age, because of TGF-β receptor downregulation. On one 
hand, this causes these MSCs to lose their ability to differentiate into myofibroblasts, giving rise 
to fibroblasts which retain TGF-β resistance and thus express higher levels of monocyte 
chemoattractant protein-1 (MCP-1). In turn, MCP1 promotes the migration of leukocytes into the 
cardiac tissue and their differentiation into myeloid myofibroblasts; as a consequence, fibroblast 
population substantially expands. On the other side, non-myeloid MSC-derived fibroblasts are 
dysfunctional and synthetize less collagen upon stimulation by TGF-β. As a result, fibrotic 
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attenuation of Notch1 signaling may contribute to the increased fibrogenesis and blunted 
regenerative response observed in the aged heart. One mechanism by which Notch1 may 
ameliorate cardiac fibrosis is inhibition of TGF-β signaling, which was shown to prevent 
fibroblast-myofibroblast transition (Sassoli et al, 2013). However, because resistance to TGF-β  
stimulation leads to MCP-1 production by aged MSCs (Cieslik et al, 2014), it cannot be excluded 
that also Notch1-induced suppression of TGF-β signaling favors MCP-1 release by these cells, 
consequently promoting leukocyte recruitment and differentiation into myeloid myofibroblasts.  
 
2. Cardiac Progenitor Cells and Aging 
Historically, the central dogma of cardiac biology has been based on the assumption that the 
heart is a terminally differentiated organ without regenerative potential, with cardiac hypertrophy 
being only secondary to enlargement and hypertrophic growth of pre-existing resident 
cardiomyocytes (Karsner et al, 1925;Leri et al, 2014). Cardiovascular disease is still a major 
socio-economic burden in Western countries, with MI the most common cause of cardiac injury. 
Although MI mortality rate has significantly decreased in the last years, thanks to significant 
progress of interventional cardiology, a growing number of MI survivors are at high risk of 
developing HF, especially as they become older. Unfortunately, in this scenario the ultimate cure 
is still represented by heart transplantation, which is limited by shortage of donors, side 
complications and is not a feasible option for elderly patients (Braunwald, 2013).  
Nevertheless, the identification in 2003 of a population of endogenous CPC residing within the 
rat heart and endowed with stem-like properties and the potential of supporting myocardial 
regeneration following MI (Beltrami et al, 2003), has revolutionized cardiac medicine. This 
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restoration potential, introducing the novel concept of multipotent CPC residing in niches 
scattered within the myocardium. Such hypothesis opened up to the fast development of CPC 
biology, by identifying their phenotype upon the expression of specific stem cell-related (c-kit, 
Sca-1) and/or early cardiac developmental (Isl1, Nkx2.5) markers, their in vitro culture 
properties (cardiospheres and cardiosphere-derived cells), or their tissue origin (epicardium-
derived progenitor cells, EPDC), as extensively reviewed elsewhere (Bollini et al, 2011). CPC 
represent a small, yet promising, reservoir of endogenous immature progenitors within the adult 
myocardium which, upon injury or appropriate stimulation, can either differentiate into the three 
main cardiovascular lineages to replace damaged cells, or can exert beneficial paracrine effects 
by releasing soluble molecules, overall resulting in a significant improvement of cardiac function 
(Bollini et al, 2011;Feng et al, 2012). So far, CPC have mainly been exploited for cell therapy 
approach, as they can be easily isolated from endocardial/myocardial biopsy obtained during 
cardiac surgery interventions and expanded in vitro prior to being transplanted back in the 
injured heart, exerting beneficial effects on the whole organ function (Barile et al, 2007;Messina 
et al, 2004;Bolli et al, 2013;Matsuda et al, 2013). Indeed, clinical trials have already been carried 
out using either c-kit+ (SCIPIO trial) and cardiosphere-derived (CADUCEUS trial) CPC in 
patients with ischemic HF or left ventricular dysfunction, showing safety and feasibility of 
autologous human CPC injection with reduction of the infarct size, increase of viable mass, and 
improvement of left ventricular function (Malliaras et al, 2014;Chugh et al, 2012). Alternatively, 
the endogenous regenerative programme of resident CPC can also be activated by appropriate 
stimulation with soluble factors by paracrine therapy, thus avoiding in vitro manipulation and in 
vivo transplantation (Urbanek et al, 2005;Rota et al, 2008;Aghila Rani and Kartha, 
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regenerative reservoir that may be activated for therapeutic purposes. Notably, CPC activation is 
widely active in both lower vertebrates (such as the zebrafish) and in neonatal mammals. Indeed, 
activation and cardiovascular differentiation of CPC following injury has been demonstrated to 
be much stronger and responsive in the neonatal mouse heart compared to the adult (Jesty et al, 
2012) and some specific subpopulations, such as the EPDC, become completely quiescent and 
unresponsive soon after birth (Smart et al, 2007), unless specifically stimulated via cardioactive 
paracrine effectors (Smart et al, 2011) this suggesting that age can significantly affect CPC 
biology. 
Since resident CPC are physiologically retained in low amount and with limited injury response 
in pathological situations, different strategies have been investigated in order to enhance their 
regenerative potential - either by their direct transplantation into the myocardium or via paracrine 
stimulation - as summarized in Table 1.  
By means of both in vitro and in vivo methods, several key aspects of human, rodent and swine 
CPC biology have been addressed, including the improvement of their survival and proliferative 
capacity, their differentiation potential and paracrine influence, with the latter mediating relevant 
cardioprotective and healing effects. Indeed, preconditioning strategy by using specific 
substances or stimuli, such as hypoxia (Yan et al, 2012;Cai et al, 2012), or by over-expressing 
the apurinic/apyrimidinic endonuclease/redox factor 1 (APE1, (Aonuma et al, 2016), have shown 
to promote CPC survival via expression of pathways involving phospho-Akt, Bcl2, TAK1 and 
NF-kB activation, while enhancing the transplanted cell therapeutic effect and increasing cardiac 
function through the activation of the SDF-1a/CXCR4 axis and downstream pro-survival 
pathways (Yan et al, 2012). Likewise, in vitro stimulation by SCF, the TGFβRI inhibitor A83-01 
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CPC proliferative potential, resulting in the activation of PTEN/PI3K/AKT, MAPK and 
MERK/ERK signaling (Ho et al, 2016;Shi et al, 2017;Vajravelu et al, 2015). Distinctive 
paracrine effects relevant to cardiac repair mechanisms have also been reported following in vivo 
transplantation of human and rodent cardiosphere-derived CPC into the injured murine cardiac 
tissue, including: i) significant inhibition of cardiomyocyte apoptosis; ii) improvement of local 
angiogenesis and iii) of cardiac function by TGF-β1/Smad signaling blocking, along with iv) the 
holding back of pathological ventricular remodeling and v) the local secretion of growth factors 
such as VEGF, IGF-1 and HGF, (de Couto et al, 2015;Malliaras et al, 2012;Tseliou et al, 2014). 
As well, growing interest has been dedicated towards the immunomodulatory competence of 
CPC in both xenogeneic and allogeneic transplantation preclinical models of rat myocardial 
infarction in order to define safety and efficacy of putative future cell therapy with mismatched 
progenitors. While rat allogeneic CPC showed to elicit negligible lymphocyte proliferation in 
vitro, xenogeneic human progenitors induced a strong response from the immune cells. This 
trend was further confirmed in vivo when showing acute rejection of human CPC within one 
week from injection and limited survival of allogeneic ones as well. Nevertheless, the treated rat 
cardiac tissue presented increased secretion of trophic factors, smaller scar size and recruitment 
of endogenous c-kit+ cells, respectively, overall suggesting a more specific paracrine role for the 
transplanted CPC, as supported by rare cardiomyogenic and angiogeneic differentiation activity 
(Malliaras et al, 2012). Indeed, more recent results further emphasized the low retention of 
transplanted rat CPC, yet showing macrophage polarization to cardioprotective phenotype away 
from M1 lineage (de Couto et al, 2015).  Remarkably, transplanted CPC have been reported to 
trigger relevant regenerative modulatory influence in stimulating resident cardiomyocyte 
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Cyclin A1-2 and E2F1 (Malliaras et al, 2012;Malliaras et al, 2013a;Malliaras et al, 2013b;de 
Couto et al, 2015) . 
Restoration of the embryonic programme of murine resident epicardial CPC has also been 
suggested by paracrine stimulation with the small peptide thymosin beta 4 in a mouse myocardial 
infarct model, as a proof of principle of reactivation of endogenous mechanism of regeneration, 
overall resulting in cardiomyocyte, endothelial and smooth muscle differentiation, up-regulation 
of phospho-SMAD1/5/8, phospho-SMAD2, SNAIL, SLUG and reactivation of the Wt1 and 
Raldh2 embryonic genes via C/EBP proteins, combined with CPC increased paracrine potential 
(Huang et al, 2012;Smart et al, 2007;Smart et al, 2011;Zhou et al, 2011). 
Notably, more recent studies have revealed that extracellular vesicles released by CPC, including 
exosomes, can recapitulate most of the significant paracrine effects exerted by these cells 
(including reprogramming of fibroblasts into a less fibrotic phenotype by suppression of 
phosphorylated Smad 2/3,4, Snail1 and increased secretion of SDF-1 and VEGF), possibly via 
direct transfer of their RNA content (i.e. microRNAs like miR-210 and miR-132, or Y RNA 
fragment), thus suggesting a new cell-free approach to still obtained progenitor-mediated 
beneficial and regenerative effects (Barile et al, 2014;Cambier et al, 2017;Ibrahim et al, 
2014;Tseliou et al, 2015).  
Noteworthy, HF and cardiovascular disease represent the most common cause of hospitalization 
for patients over 65 years. Aging is associated with a progressively increased risk of ischemic 
coronary disease and MI (Thomas and Rich, 2007). Hence, the impact of aging on CPC biology 
and on their regenerative potential has to be evaluated in details in order to identify a working 
strategy. Several preclinical and clinical evidences support the hypothesis that CPC residing in 
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responsive to external stimulation, thus penalizing any possible regenerative strategy in the event 
of injury (Hu et al, 2014). In particular, nucleostamin and Pin1 have been lately identified as 
playing a key role in maintaining CPC function, as their silencing has revealed to significantly 
induce premature cell senescence and to affect their proliferative potential (Table 1)(Hariharan et 
al, 2015;Toko et al, 2014) . 
While the number of human CPC seems to increase in the old myocardium, especially in women 
(Kajstura et al, 2010), a recent study showed that the percentage of human c-kit+ CPC can be 
negatively correlated with aging, especially when associated with age-related disease, such as 
diabetes mellitus and coronary heart disease, resulting in the depletion of the progenitor pool, 
overall affecting the endogenous heart potential (Hu et al, 2014). Therefore, a growing body of 
evidence suggests that the aged heart can be compromised from chronological CPC aging. 
Indeed, within the old myocardium the migratory capacity of human c-kit+ CPCs declines with a 
putative mechanism described in the alterations of signaling regulated by the receptor EphA2 
controlling human CPC motility, which, in turn, are caused by age-associated accumulation of 
reactive oxygen species and a significantly higher oxidative stress. Besides, old human CPC with 
altered trafficking are unable to translocate within the myocardial tissue, with important 
consequences for cardiac repair (Goichberg et al, 2013). Likewise, senescent CPC, which have 
lost their telomerase activity because of aging, may give rise to structurally old cardiomyocytes 
destined to become less functional, with severely depressed mechanical performance and a 
marked tendency to apoptosis, along with the manifestation of an aging cardiac phenotype 
(Kajstura et al, 2010). Cardiosphere-derived cells (CDC) isolated from aged mice showed a 
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of their clonogenic potential, suggesting failure of regenerative potential with age (Hsiao et al, 
2014).  
Thus, there is mounting claim for finding novel approaches besides current conventional medical 
care. Indeed, to be clinically feasible, CPC must be isolated and expanded from aged and/or 
diseased tissue. In such scenario, CPC functional lifespan might be ensured via the appropriate 
stimulation by protective soluble molecules (such as insulin-like growth factor-1) preserving 
telomere length and the regenerative potential (Siddiqi and Sussman, 2013); pharmacological 
approaches based on ACE-inhibitors blocking the angiotensin II signaling and oxidative stress 
affecting CPC, have also been suggested (Cesselli et al, 2013). Moreover, novel strategies 
aiming at preserving the pool of competent CPC might be based on defining the specific 
environmental clues and molecules orchestrating and supporting the transient regenerative 
potential of the early/neonate heart, a process that has been showed to temporally correlate with 
the existence of functional CPC. This might represent an ideal strategy to maintain and restore 
the progenitor potential while correcting their impairment due to the aging process and temporal 
limitations (Jesty et al, 2012;Zaruba et al, 2010;Beltrami et al, 2012). 
 
3. Notch Signaling in the Heart 
The Notch pathway is an ancient system of communication between adjacent cells. In mammals 
there are four Notch receptors (Notch 1-4) and five ligands (Delta-like ligand (Dll)1, 3, 4 and 
Jagged1 and -2) located on cell surface and characterized by the presence of a DSL (Delta, 
Serrate, and Lag2) domain required to interact with Notch (D'Souza et al, 2010).  Binding of a 
ligand to the receptor triggers two proteolytic cleavages releasing the active form of Notch 
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immunoglobulin kappa J region (RBP-Jk) and regulates the transcription of genes related to cell 
proliferation, survival, and cell-type specification. The most studied Notch target genes belong to 
Hes and Hey families, which are negative regulator of transcription (Espinoza and Miele, 2013), 
(Figure 2) and (Table 2). Recent studies have shed further light on the complexity of Notch 
signaling and have shown that the pool of genes modulated by Notch is larger than previously 
thought, greatly differs among cell types, and is context-dependent in the same cell (Andersson 
et al, 2011). Furthermore, non-canonical ligands have been identified lacking the DSL domain 
and comprising a group of structurally diverse proteins that include integral and 
glycosylphosphatidylinositol (GPI)-linked membrane as well as secreted proteins (D'Souza et al, 
2010). 
 
Notch plays a major role during heart development, patterning the embryonic endocardium, 
enabling region-specific differentiation and critical interactions of the endocardium (or its 
derived mesenchyme) with other cardiac tissues (like cardiac neural crest, myocardium), so that 
specialized structures (as cardiac valves and chambers) are generated (D'Amato et al, 
2016b;MacGrogan et al, 2016;Luxan et al, 2016;D'Amato et al, 2016a), (Figure 2)  and (Table 
2). A large body of evidence suggests that Notch exerts a critical function in the adult overloaded 
or damaged myocardium as well, even though less is known about Notch role within the heart 
during post-natal life compared to embryonic development (Ferrari and Rizzo, 2014), (Figure 2) 
and (Table 2). Neonatal cardiomyocytes rapidly proliferate within the very early post-natal 
stages and express high levels of Notch1. Conversely, in the adult myocardium these cells lose 
the ability to proliferate and down-regulate Notch signaling. Notch1 is reactivated in 
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counteracts cardiomyocytes apoptosis and hypertrophy (Ferrari and Rizzo, 2014);Nistri et al, 
2017). Consistently, the expression of components belonging to its signaling pathway has also 
been observed in myocardial biopsies from HF patients (Ferrari and Rizzo, 2014). However, it is 
possible that Notch activation following cardiac injury is protective only if temporary, since 
Campa et al. have shown that prolonged activation of Notch1 in cardiomyocytes is detrimental 
and induces apoptosis (Campa et al, 2008).  In agreement with the hypothesis suggesting that 
prolonged and/or dysregulated Notch signaling could be detrimental for heart function,  elevated 
levels of non-canonical Notch ligand periostin were found to be associated to myocardium 
fibrosis (Zhao et al, 2014) and to symptoms severity in dilated cardiomyopathy (Norum et al, 
2017) and, similarly, elevated levels of canonical Notch ligand Dll1 have been linked to worse 
prognosis of dilated cardiomyopathy (Norum et al, 2016) , HF (Norum et al, 2017)  and 
symptomatic aortic stenosis (Abraityte et al, 2015).  
 
Notch activation in the damaged myocardium has been linked to CPC and MSC regulation 
(Ferrari and Rizzo, 2014). Indeed, Notch1 is present on the membrane of CPC in its inactive 
form and, following MI, it gets activated by Jagged1 exposed on the surface of adjacent 
cardiomyocytes. Notch activation, in turn, induces the transcription factor Nkx2.5, which is 
involved in the expression of early cardiomyogenic transcripts and in the inhibition of vascular 
cells markers (Boni et al, 2008); it also stimulates CPC growth, survival and differentiation via 
mTORC1, while enhancing their lineage commitment and protective signaling (Gude et al, 
2015). Furthermore, in a mouse model of pressure-overloaded myocardium, overexpression of 
Jagged1 by cardiomyocytes favoured the CPC differentiation into Nkx2.5-cardiac precursor 
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β/connective tissue growth factor (Nemir et al, 2012). Notably, while inhibition of fibrosis by 
Notch has also been observed in vitro, where  activation of Notch interfered with TGFβ-induced 
cardiac fibroblast-into-myofibroblast transition (Fan et al, 2011;Sassoli et al, 2013), a population 
of GFP-genetically labelled epicardial CPC from transgenic Notch reporter (TNR) mice showed 
a dynamic Notch-dependent activation following myocardial injury  - obtained as either by 
myocardial infarction or by thoracic aorta banding – with modest cardiogenic potential and a 
more pronounced commitment to the fibroblast lineage (Russell et al, 2011). 
Notch plays a major role also in the regulation of MSC, as suggested by a study showing that 
deletion of Notch1 in these cells impairs their recruitment, proliferation, and survival leading to 
decreased ability to repair the myocardium damage compared to MSC with functional Notch1 
signaling (Ferrari and Rizzo, 2014). Consistently, pathological conditions such as HF affect 
MSC functions and deregulates Notch pathway (Ferrari and Rizzo, 2014). The influence of 
Notch on triggering the MSC cardioprotective potential could be synergic to CPC activation, as 
suggested by an in vitro study showing enhanced proliferation of immature cardiomyocytes and 
Notch1 activation by co-culture with Jagged-1 expressing MSC (Sassoli et al, 2011). The critical 
role of Notch in stem cell-mediated cardiac repair has also been investigated in a preclinical 
mouse model of MI following doxorubicin treatment (DOX-MI mice) (Merino and Singla, 
2014). The study showed the pivotal role of Notch in mediating the protective effect obtained 
following transplantation of embryonic stem (ES) and induced pluripotent stem (iPS) cells, 
overall improving heart function and reducing adverse cardiac remodelling.(Merino and Singla, 
2014). 
In addition to fibrosis, down-regulation of calcium-handling proteins with decreased intracellular 
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dysfunction (Loffredo et al, 2014). Crosstalks between the Notch and Ca2+ signaling networks 
have been observed in cardiomyocytes (Kasahara et al, 2013) and, in leukemia cells, inhibition 
of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) impairs the maturation and 
activity of Notch1 (Roti et al, 2013). Similarly, there is evidence of reactive oxygen species 
(ROS) modulation by Notch in the myocardium. In vitro studies have shown that moderate 
oxidative stress induces the expression of cardiac markers in MSC through the activation of 
Notch signaling (Boopathy et al, 2013) and that Notch deficiency aggravates postburn 
myocardial injury through increased ROS levels (Cai et al, 2016).  
Notch signaling is active in the endothelial (EC) and vascular smooth muscle cells (VSMC) of 
cardiac vessels. The Notch pathway controls angiogenesis and protects the endothelium from 
dysfunction caused by inflammatory cytokines, ischemia, and turbulent blood flow (Rizzo et al, 
2012); moreover, it controls proliferation, survival, and function of VSMC (Ferrari and Rizzo, 
2014). Studies in mouse model of MI have shown that activation of Notch1 signaling improves 




Notch in the Aged Heart 
Whether and how Notch signaling is affected in the aging heart has not been extensively 
investigated yet (Figure 2) and  (Table 2). Lower expression of Notch1, Jagged1, and Delta-like 
ligand 1 has been observed in skeletal muscle biopsies from older men compared with muscle 
from younger men (Carey et al, 2007). The reduced activation of Notch in the skeletal muscle 
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enhances the expression of the Notch ligand (Delta), increases Notch activation, and enhances 
their proliferation in vitro (Conboy et al, 2003;Conboy et al, 2005).  
Hastening of cardiomyocyte apoptosis and senescence have been proposed as mechanisms 
underlying decreased hemodynamic performance and increased risk of HF in the elderly 
(Sussman and Anversa, 2004). Despite Notch signaling components were not found among the 
age-regulated genes in mouse ventricular cardiac muscle cells (Bodyak et al, 2002), the 
hypothesis that aging impairs Notch activation in cardiomyocytes under ischemic or overloaded 
conditions or in other myocardial cell types, cannot be excluded. Consistently, microarray 
studies have shown that ischemic stress generates a much greater degree of contractile 
impairment and cellular damage in aged versus young hearts and these changes are associated 
with selective changes in transcription levels of Ca2+, Wnt, Notch, and G-protein coupled 
receptor signaling pathways in aged versus young hearts (Ashton et al, 2006).  In aging mice, the 
impairment in MSC function has been linked to Notch inhibition (Mutyaba et al, 2014). Old 
mice exhibit a decrease in MSC number, with limited proliferation, adipogenesis, and 
inconsistent osteogenesis associated to decreased basal Notch signaling activity, even though 
these cells are fully responsive to Jagged1 stimulation (Mutyaba et al, 2014). Taken together, 
these studies suggest that aging could interfere with the activation of Notch required to reduce 
pathological remodeling in the damaged myocardium.  
The effects of aging on Notch within the vasculature have been investigated in a rat model of 
thoracic aorta injury by balloon catheter, in which aging-exaggerated proliferation of VSMCs 
has been linked to the attenuation of Jagged1 expression in EC (Wu et al, 2008). In this artery 
injury model, the interaction of Jagged1 on EC with Notch3 on VSMC in the intima prevented 
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reduced apoptosis of VSMC plays a key role in aging-associated enhanced response to vascular 
injury. VSMC co-cultured with senescent EC, expressing reduced levels of Jagged1 compared 
with young EC, exhibited decreased susceptibility to H₂O₂-induced apoptosis compared with 
those co-cultured with young EC (Qian et al, 2011). It is unknown whether Jagged1 
downregulation is involved in the exaggerated neointimal hyperplasia after percutaneous 
coronary intervention in the elderly as well as in aging-related vascular remodeling and 
stiffening . Dysregulation of Notch signaling could play a role in the progressive calcification of 
the aortic valve, which affects a large number of people over 65-years old, since elevated Notch1 
levels and enhanced Notch1 activation were found to play a major role in augmentation of the 
pro-osteogenic response of interstitial cells of stenotic valves (Zeng et al, 2013). 
 
Aging is associated with impaired vascular endothelial function (Donato et al, 2007), which is 
implicated in the HF pathophysiology, particularly of HF with preserved ejection fraction (Lam 
and Brutsaert, 2012). As previously discussed, the Notch pathway has a protective role in the 
endothelium (Rizzo et al, 2012) and there is evidence of an age-related endothelial Notch 
dysregulation. During vein graft adaptation to the arterial environment, both Dll 4 and Notch4 
expression were found to be downregulated in an endothelial aged background, compared to a 
young one, and  loss of Notch4 was linked to loss of attenuation of neointima (Kondo et al, 
2011). Currently, it is not known whether aging leads to downregulation of endothelial Notch1, 
which is required to prevent the expression of calcification in the endothelium of aortic valve 
(White et al, 2015). If this were the case, age-related calcific aortic stenosis could be linked to 
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Gender is associated to differences in symptoms and susceptibility to specific cardiovascular 
diseases which have been ascribed to gonadal hormones (Arnold et al, 2017). Specifically pre-
menopausal women are protected against ischemic heart disease compared to age-matched men 
and this protection disappears after menopause due, as suggested by many studies, to the 
dropping levels of estrogens (Hayward et al, 2000).  The Notch signaling is modulated by 
estrogens in estrogen receptor positive- breast cancer cell lines (Rizzo et al, 2012), in neuronal 
(Ruiz-Palmero et al, 2011) and in endothelial cells (Caliceti et al, 2013). In endothelial cells, 
treatment with 17β-estradiol increases the levels of active Notch1 (Caliceti et al, 2013) which is 
required to protect the endothelium against TNF -induced apoptosis (Fortini et al, 2017).  
Considered the protective role of Notch in the endothelium (Theodoris et al, 2015;Pannella M et 
al, 2014;Briot et al, 2015), the increased  risk of ischemic heart disease in post-menopausal 
women  (Hayward et al, 2000) and in breast cancer women undergoing aromatase inhibitor 
treatment  (Seruga et al, 2014;Abdel-Qadir et al, 2016), could be related to a decrease of 
endothelial Notch1 signaling caused by low levels of estrogens. Similarly, since estrogens 
controls the expression of periostin in breast cancer (Ratajczak-Wielgomas et al, 2017), the lack 
of estrogens in post-menopausal women could lead to elevated levels of periostin, thus affecting 
cardiac function (Norum et al. 2016).  Studies in patient are needed to assess the involvement of 
Notch in the observed differences in cardiovascular risk or symptoms among genders.  
 
4. Conclusions 
The knowledge of cellular events occurring with age in the heart has dramatically expanded in 
the last decade and is expected to further grow in years to come. It is now clear that impaired 
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other events are likewise important. In particular, accumulating experimental evidence highlights 
the importance of basal activation of fibroblasts with fibrosis in spite of a defective response to 
injury, as well as of depletion and dysfunction of CPC. Detailed investigation of the signaling 
pathways involved in all these cellular abnormalities, such as the Notch one, may allow the 
discovery of novel therapies for age-related cardiac disease. As discussed in the previous 
paragraphs, the activation of myocardial Notch i) prevents the transformation of cardiac 
fibroblasts in myoblasts, ii) promotes the proliferation of CPC, and iii) favours their 
differentiation into cardiomyocytes, rather than myofibroblasts. In resemblance with what 
observed in the vascular endothelium, in which aging attenuates Jagged1 expression, it would be 
of great interest to determine whether fibrotic and reduced regenerative responses in the aging 
heart are caused by the attenuation of Notch signaling due to reduced levels of Jagged1. The 
weak responsiveness to TGF-β in the aging heart would be consistent with this hypothesis, since 
it has been observed that, at least in MSC, TGFβ induces Jagged1 (Kurpinski et al, 2010). 
Aging-related and attenuated expression of endothelial Jagged1 could potentially affect also 
angiogenesis and endothelium functions, thus promoting the pathological remodeling of the aged 
heart. In this scenario, reinstating the pre-existing levels of Jagged1 could help preventing altered 
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Figure Legend 
Figure 1. Effects of aging on cardiac fibroblasts. Downregulation of the oxidized low density 
lipoprotein receptor-1 (LOX-1) in aged fibroblasts has been associated with reduced 
proliferation, cytoskeletal disorganization and increased collagen secretion. Differentiation of 
precursors into myofibroblasts can be induced by a variety of stimuli (grey boxes). Cardiac 
mesenchymal stem cells (MSC) of non-myeloid origin become unresponsive to transforming 
growth factor (TGF)-β with aging, and thus they loose their ability to differentiate into 
myofibroblasts. Instead, they give rise to mesenchymal myofibroblasts which produce less 
collagen in response to TGF-β and release large amounts of monocyte chemoattractant protein-1 
(MCP-1). MCP-1 promotes the migration of leukocytes in the cardiac tissue and their 
differentiation into myeloid myofibroblasts. Dysfunction of mesenchymal fibroblasts and 
expansion of the myeloid myofibroblasts pool may account for the impairment in scar formation 
and the enhancement in interstitial collagen deposition observed in the aged heart. Finally, 
cardiac injury was shown to induce epicardial cardiac progenitor cells (CPC) to commit to the 
fibroblast lineage via Notch1 activation 
 
Figure 2. Expression of isoforms of Notch receptors , ligands,  effector genes and proteins 
involved in the modulation of this pathway in fetal, adult and aged heart.  The names of the 
enzymes involved in Notch processing are shown in red. The question mark indicates lack of 
data on that particular protein/gene. The maturation process of the Notch receptor involves 
cleavage in the Golgi complex by Furin. The activation of Notch signaling pathway is mediated 
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triggers two proteolytic cleavages by ADAM and the γ-secretase releasing the intracellular 
domain of the Notch receptor (NIC), NIC translocates into the nucleus and interacts with the 
transcription factor RBP-JK, and converts it into a potent transcriptional activator of downstream 
target genes Abbreviations: ADAM, A Disintegrin And Metalloprotease; CM, cardiomyocytes; 
CSC, cardiac stem cell; Dll1-4, Delta-like ligands 1,4;  DLK1, Delta-like 1 homologue; DLX2, 
Deltex E3 Ubiquitin Ligase 2; EC, endothelial cells; ER, endoplasmic reticulum; Hey, hes 
related family bHLH transcription factor with YRPW motif;  Hes,  hes family bHLH 
transcription factor; MAM, transcriptional coactivator Mastermind;  MF, myofibroblasts; MSC, 
mesenchymal stem cells; NFL, full lenght Notch; NIC, intracellular active Notch; POFUT1, 
protein O-fucosyltransferase 1; RBP-Jk, transcription factor  recombination signal binding 
protein for immunoglobulin kappa J region; S, serum; VSM, Vascular Smooth Muscle Cells; 
WH, whole heart. 
 
 
Figure 3. Effects of aging on cardiac Notch pathway. The aged heart is characterized by 
increased fibrosis and reduced regenerative response affecting cardiac function and setting the 
stage for pathological remodelling. These processes are regulated by Jagged1-activated Notch 
signaling. Thus, Jagged1 could represent a new therapeutic target to reduce fibrotic response and 
replenish the CPC pools within the aging myocardium (CPC, green; myofibroblasts, red; 
cardiomyocytes, pink; collagen fibers, red/green rods). 
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APE1: APurinic/apyrimidinic Endonuclease/redox factor 1; BCL2: B-cell lymphoma 2; BCL-
XL: B-cell lymphoma-extra large; C/EBP: CCAAT/enhancer binding protein; CDC: 
Cardiosphere-Derived Cells; CdK: Cyclin-Dependent Kinase; CoPP: Cobalt Protoporphyrin; 
Cox2: Cyclooxygenase 2; CPC: Cardiac Progenitor Cells; CS: CardioSphere cells; EGF: 
Epidermal Growth Factor; EPDC: Epicardium-Derived progenitor Cells; EV: Extracellular 
Vesicles; Ex: Exosomes; FGF: Fibroblast Growth Factor; HGF: Hepatocyte Growth Factor; 
HUVEC: Human Umbilical Vein Endothelial Cells; i.c.: intra-coronary infusion; i.m.: intra-
myocardial injection; i.p.: intra-peritoneal; I/R: Ischemia/Reperfusion; IGF-1: Insulin Like 
Growth factor-1;IL-10: InterLeukin-10; LV: Left Ventricle; MAPK: Mitogen-Activated Protein 
Kinase; MCL-1: Induced myeloid leukemia cell differentiation protein; MI: Myocardial 
Infarction; miR-21: microRNA 21; MLR: Mixed Lymphocyte Reaction; MRI: Magnetic 
Resonance Imaging; NVCM: Neonatal Ventricular CardioMyocytes; pAkt: phosphorylated Akt; 
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chromosome ten; Raldh2: Retinaldehyde dehydrogenase 2; Rb: Retinoblastoma; Ref.: 
Reference; Sca-1:Stem Cell Antigen-1; SCF: Stem Cell Factor; SDF-1: Stromal Derived Factor-
1; TAK1: -Activated Kinase 1; TGF-β-1: Transforming Growth Factor Beta-1; TGFβRI: TGF-
β type I receptor; TLR: Toll Like Receptors; Tβ4; Thymosin Beta 4; VEGF: Vascular 
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Table 2. Expression of proteins and target genes of the Notch pathway in the heart at 
different stages of life 








Fetal  Jagged1, 
Jagged2 Dll1, 
Dll4            
(whole heart) 




(whole heart)  
Hey1, Hey2   
(whole heart) 
(Susan-Resiga et al, 
2011;High and 
Epstein, 2008;de la 
Pompa, 
2009;Albrecht et al, 
2006)(Shi et al, 
2003) 




















Hey1, Hey2, Hes1 
(cardiomyocytes, 





Wang et al, 
2009;Boni et al, 
2008;Croquelois et 
al, 2008;Kratsios et 





Notch2, Notch4  
(endothelial cells) 
   (Briot et al, 
2015;Norum et al, 
2016;Shutter et al, 
2000) 
DLK1, periostin, 
(whole heart,  
serum) 




 (Abraityte et al, 
2015;Norum et al, 
2017;Ragot et al, 
2016;Zhang et al, 
2016;Zhao et al, 
2014) 












(Ashton et al, 
2006;Mutyaba et al, 
2014) 
 
Abbreviations: ADAM, A Disintegrin And Metalloprotease; Dll1-4, Delta-like ligands 1,4;  
DLK1, Delta-like 1 homologue; DTX2, Deltex E3 Ubiquitin Ligase 2;Hey, hes related family 
bHLH transcription factor with YRPW motif; Hes, hes family bHLH transcription factor; 
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Figure 3 
